Grand Pharma and Donghai Capital to form joint venture for cardiovascular medical devices

Grand Pharmaceutical Group (00512) announced plans to form a joint venture in Hong Kong with Donghai Capital, a subsidiary of its controlling shareholder China Grand Enterprises. The JV, with a total investment of about $15 million, will focus on selling cardiovascular medical devices, including investing in North American manufacturers and establishing sales channels in China.

“2017年11月13日，公司拟与控股股东中国远大旗下东海资本，在香港成立合营企业，其中，由公司持有不多于49.9%股本权益。”beta.zhitongcaijing.com

• 1 source
• beta.zhitongcaijing.com远大医药(00512)拟与东海资本成立合营 以销售心脑血管医疗设备Nov 13, 2017

Summarized from public sources; check the original articles before acting on it.